Names and pronunciation
(ah-loss′a-tron) Lotronex
PDF page 54
Drug reference
(ah-loss′a-tron) Lotronex
PDF page 54
Func. class.: Anti-IBS agent
PDF page 54
USES: Severe, chronic, diarrhea- predominant irritable bowel syndrome (IBS) in women who have failed conventional therapy
PDF page 54
CONTRAINDICATIONS: Crohn’s disease, severe hepatic disease, diver- ticulitis, toxic megacolon, GI adhe- sions/strictures/obstruction/perfora- tion, thrombophlebitis, ulcerative colitis
PDF page 54
Black Box Warning: Ischemic colitis, se- vere constipation
PDF page 54
DOSAGE AND ROUTES • Adult woman: PO 0.5 mg bid, may increase to 1 mg bid after 4 wk if well tolerated; if symptoms are not controlled after 4 wk of treatment with 1 mg bid, discontinue
PDF page 54
Available forms: Tablets 0.5 mg, 1 mg HIGH ALERT
PDF page 54
• Adult woman: PO 0.5 mg bid, may increase to 1 mg bid after 4 wk if well tolerated; if symptoms are not controlled after 4 wk of treatment with 1 mg bid, discontinue
PDF page 54